HS6ST2 and uveal melanoma: As determined by KM OS analysis, HS6ST2 was a protective factor for patients with bladder urothelial carcinoma and rectum adenocarcinoma but a risk factor for patients with kidney renal papillary cell carcinoma and uveal melanoma (Fig. 3B–E).